LGC acquires Berry & Associates

News - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.

27 September 2018
LGC acquires LINK and strengthens its oligo reagents offering

News - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

19 July 2017
LGC acquires Douglas Scientific to expand its high-throughput PCR platform offering

News - LGC announces that it has acquired a majority stake in Douglas Scientific

06 April 2016
LGC acquires Prime Synthesis, Inc., and strengthens its supply of oligo synthesis materials

News - PSI products complement existing genomics offering

18 November 2016
LGC acquires Biosearch Technologies and extends its expertise in the qPCR market

News - Acquisition enables enlarged Genomics division to deliver unique product and laboratory services offering for core qPCR and end point PCR applications

15 April 2015
Julian Braybrook appointed UK Government Chemist

News - LGC announced today that Dr Julian Braybrook has been appointed the UK Government Chemist. He replaces Dr Derek Craston, who completed two terms of five years each in this Office.

01 June 2018
LGC acquires BioAutomation Corporation

News - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments.

01 May 2018
LGC acquires Lucigen, strengthening its reagents offering to the genomics market

News - Lucigen offers extensive enzymology expertise and a wide portfolio of molecular biology reagents

16 February 2018
LGC announces new name for integrated genomics brand, Biosearch Technologies

News - LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

18 October 2018
Co-Diagnostics, Inc. and LGC Sign License Agreement for CoPrimer Technology

News - Exclusive license agreement relates to use of CoPrimerâ„¢ technology for both research and commercial applications.

31 October 2018